DataMeds AI Signs MoU With Florida HMO To Deploy The Health Lives Here Mobile App For GLP-1 Management
Benzinga Newsdesk 2 hours ago
News
DataMeds AI, Inc. ("DataMeds SI," "DataMEDS" or the "Company") (NASDAQ:MEDS), a healthcare company that integrates its health information technology and physical infrastructure with its
DataMeds AI, Inc. ("DataMeds SI," "DataMEDS" or the "Company") (NASDAQ:MEDS), a healthcare company that integrates its health information technology and physical infrastructure with its EinsteinRx™ artificial intelligence platform and PharmacyChain™ blockchain-enabled smart contracts platform, today announced that it has signed a Memorandum of Understanding ("MOU") with a Florida-based health maintenance organization (HMO), whose name is being withheld at its request, to deploy the Health Lives Here (HLH) mobile application for members initially focused on helping members on GLP-1 receptor agonist medications better manage their treatment. The HMO expects to have between 25,000 and 30,000 members for 2027 following open enrollment that closes on December 8, 2026. NFL Alumni Health, a Health Lives Here strategic marketing partner, expects to support member health engagement efforts.
The program outlined in the MOU aims to improve medication adherence, Healthcare Effectiveness Data and Information Set (HEDIS) and Centers for Medicare & Medicaid Services (CMS) star ratings, initially in obesity and diabetes members. The HMO serves Medicare Advantage members including Chronic Special Needs Plan (C-SNP), and Dual Eligible Special Needs Plan (D-SNP) beneficiaries.
The proposed program would generate revenue for DataMEDS on a 'per member per month' (PMPM) model for use of the HLH app for all HMO members, with additional revenue generated through an add-on GLP-1 receptor agonist drug patient management program. Additional opportunities for DataMEDS revenue generation related to pharmacy dispensing, diagnostic lab testing and medical food products may arise as part of the opportunity. DataMEDS' retail pharmacy Corexa Pharmacy is in-network with the HMO's pharmacy benefits manager (PBM) and Medicare. The Company's diagnostic laboratory, Helomics, is in-network with Medicare. The companies expect to execute definitive agreements in the fourth quarter of 2026 to begin rolling out the app to members in the first quarter of 2027. The MOU is non-binding and is subject to definitive agreements.
